UBS Preps Acqui Deal

21 Jun 2007

Harlan Sprague Dawley has tapped the loan market for financing to back its acquisition of SafePharm.

Harlan Sprague Dawley has tapped the loan market for financing to back its acquisition of SafePharm. UBS leads the loans, which consist of a six-year, $30 million super-priority revolver divided between U.S. dollars and euros, and a seven-year, $330 million first-lien term loan. Pricing is LIBOR plus 2 ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial